Search Within

Tony Taldone

Formats
  1. Journal Article (59)
  2. Meeting Abstract (31)
  3. Book Section (2)
  4. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (93)
  2. GSK Faculty (90)
  3. Sloan Kettering Institute Faculty (90)
  4. Center for Hematologic Malignancies (88)
  5. Hematologic Malignancies Research (88)
  6. Molecular Pharmacology and Chemistry Program Faculty (88)

More Groups

People
  1. Gabriela Chiosis (88)
  2. Anna Rodina Balingcongan (39)
  3. Hardik Patel (24)
  4. Maria Caldas Lopes- Vazquez (18)
  5. Pengrong Yan (17)
  6. Nagavarakishore Pillarsetty (16)

More People

Years
  1. 2023 (1)
  2. 2021 (3)
  3. 2020 (6)
  4. 2019 (8)
  5. 2018 (1)
  6. 2017 (3)

More Years

Publications
  1. Blood (15)
  2. Cancer Research (13)
  3. Journal of Medicinal Chemistry (4)
  4. Nature Communications (4)
  5. Journal of Labelled Compounds and Radiopharmaceuticals (3)
  6. Bioorganic & Medicinal Chemistry (2)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Hematology (15)
  3. American Chemical Society (7)
  4. Nature Publishing Group (7)
  5. Pergamon-Elsevier Science Ltd (7)
  6. Cell Press (6)

More Publishers

Results (93)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epichaperome abundance predicts response to the epichaperome inhibitor, Puh-71, in acute myeloid leukemia
    Meeting Abstract

    Tavakkoli, M.; Kaner, J. D.; Sahil, S.; Taldone, T.; Merugu, S.; Chiosis, G.; Roboz, G. J.; Guzman, M. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Harnessing the epichaperome as a therapeutic approach in multiple myeloma
    Meeting Abstract

    Lopes, E. C.; Wang, T.; Jayabalan, D. S.; Taldone, T.; Monge, J.; Contreras, J.; Winnie, Y.; Trujillo, V.; Palak, P.; Lombardi, N.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • PTPN11 mutated acute myeloid leukemia (AML) features an abundant epichaperome network and is sensitive to the epichaperome inhibitor PU-H71
    Meeting Abstract

    Kaner, J. D.; Tavakkoli, M.; Toudic, L.; Stevens, B. M.; Jordan, C. T.; Taldone, T.; Chiosis, G.; Ritchie, E. K.; Desai, P.; Samuel, M. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Biomarker based targeting of the epichaperome as a novel therapeutic approach for multiple myeloma (MM)
    Meeting Abstract

    Lopes, E. C.; Wang, T.; Jayabalan, D.; Monge, J.; Taldone, T.; Contreras, J.; Yip, W.; Panchal, P.; Sharma, S.; Digwal, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90
    Journal Article

    Huck, J. D.; Que, N. L. S.; Immormino, R. M.; Shrestha, L.; Taldone, T.; Chiosis, G.; Gewirth, D. T.
    Journal of Biological Chemistry (2019)

    Fulltext@MSK | Save
  • Structures of Hsp90α and Hsp90β bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity
    Journal Article

    Huck, J. D.; Que, N. L. S.; Sharma, S.; Taldone, T.; Chiosis, G.; Gewirth, D. T.
    Proteins: Structure, Function and Bioinformatics (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons
    Journal Article

    Kishinevsky, S.; Wang, T.; Rodina, A.; Chung, S. Y.; Xu, C.; Philip, J.; Taldone, T.; Joshi, S.; Alpaugh, M. L.; Bolaender, A.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Hsp90 facilitates oncogene-induced metabolic reprogramming in B-cell lymphomas
    Meeting Abstract

    Vidal, M. N. C.; Krumsiek, J.; Patel, J.; Yang, S. N.; Phillip, J. M.; Marullo, R.; Taldone, T.; Inghirami, G.; Melnick, A.; Chiosis, G.; more...
    Blood (2017)

    Fulltext@MSK | Save